Skip to main content

Cancer Research 499

The Cancer Research Sub-Plan in Life Sciences was designed to offer senior undergraduate students a hands-on research experience, integrated with small group courses covering the process of science and key themes in cancer biology and genetics.  Core components of the program include the 4th year research project (CANC 499), as well as a seminar in Cancer Biology and Therapeutics (CANC 440).

While the program is centred around molecular aspects of cancer biology, the education students receive is widely applicable.  Historically, graduates of the program go on to Professional and Graduate Studies in roughly equal numbers.

More information about the Cancer Research Sub-Plan in Life Sciences can be found on the Cancer Research Institute website.

2022 - 2023 supervisors in CANC 499:

Dr. Sheela Abraham  has accepted three CANC project students for 2022-2023 and will not be taking more project students for the 2022-2023 academic year.

Dr. John Allingham has accepted a CANC project student for 2022-2023.

Dr. Scott Davey has accepted two CANC project students for 2022-2023.  Dr. Davey is also co-supervising another CANC 499 project with Dr. Feilotter.  Dr. Davey will not be taking on any additional students for 2022-2023.

Dr. Scott Davey and Dr. Harriet Feilotter  have jointly accepted a CANC project student for 2022-2023.  

Dr. Harriet Feilotter . has accepted one CANC project student for 2022-2023.

Dr. Lois Mulligan will accept one CANC project student for 2022-2023. Title: Exploring the roles of the RET kinase in human cancer

Dr. Christopher R. Mueller has accepted two CANC project students for 2022-2023.  Dr. Mueller will not be taking on any additional students for 2022-2023.

Dr. Chris Nicol has accepted one CANC project student for 2022-2023.

Dr. Neil Renwick has accepted one CANC project student. for 2022-2023.

********************************************

2021 - 2022 supervisors in CANC 499: